** Shares of drugmaker ANI Pharmaceuticals ANIP.O rise 1.5% to $72.60
** Raises 2025 per-share profit forecast to between $6.27 and $6.62, compared with between $6.12 and $6.49 earlier
** Expects full-year revenue of $768 million-$793 million, compared with previously projected $756 million-$776 million
** Quarterly revenue jumped 43.4% to $197.1 million, above analysts' estimates of $180.68 million - data compiled by LSEG
** Including session's moves, stock up 33% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。